PLX Operating Cash Flow (Statement)
Protalix Biotherapeutics Inc · Operating Cash Flow (Statement)
PLX Operating Cash Flow (Statement)
Latest reported-$10.40Mperiod ending
PLX Quarterly Cash from Operations (-$70.00K → -$10.40M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
PLX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 655,309 | |
| -85,685 | |
| 135,619 | |
| -47,573 | |
| -57,948 | |
| -83,206 | |
| -89,915 | |
| -394,340 | |
| -412,602 | |
| -511,280 | |
| -380,000 | |
| -860,000 | |
| 410,000 | |
| -80,000 | |
| -170,000 | |
| -250,000 | |
| -110,000 | |
| -80,000 | |
| -10,000 | |
| -70,000 |